Newsroom - Tozaro

MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification

August 5, 2024

Bedfordshire, UK, 06 August 2024: MIP Discovery today announced the Company’s rebrand to Tozaro, completing its transition to becoming a …

Tozaro closes £7M Series A financing to drive commercialization in cell and gene therapy space

February 19, 2024

By celf_admin

Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making …

Tozaro (formally MIP Discovery) secures significant funding to support development of global rapid response diagnostics

February 1, 2023

By celf_admin

Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale …